Development and validation of the Neuropathic Pain Symptom Inventory

Pain

Volumn 108, Issue 3, 2004, Pages 248-257

  Bouhassira, Didier ^a,b   Attal, Nadine ^a,b   Fermanian, Jacques ^c   Alchaar, Haiel ^d   Gautron, Michèle ^a,b   Masquelier, Etienne ^e   Rostaing, Sylvie ^f   Lanteri Minet, Michel ^d   Collin, Elisabeth ^g   Grisart, Jacques ^e   Boureau, François ^f  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d PASTEUR HOSPITAL   (France)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f HÔPITAL SAINT ANTOINE   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Evaluation; Neuropathic pain; Psychometric validation; Self questionnaire

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ALLODYNIA; ARTICLE; BELGIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DYSESTHESIA; FEMALE; FRANCE; HUMAN; HYPERALGESIA; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NEUROPATHIC PAIN SYMPTOM INVENTORY; PAIN ASSESSMENT; PAIN CLINIC; PARESTHESIA; PILOT STUDY; PRIORITY JOURNAL; PSYCHOMETRY; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RELIABILITY; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PAIN; PAIN MEASUREMENT; PILOT PROJECTS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 12144288164     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.12.024     Document Type: Article

References (32)

1. Attal N., Gaude V., Brasseur L., Dupuy M., Guirimand F., Parker F., Bouhassira D. Intravenous lidocaine in central pain: a double blind placebo controlled psychophysical study. Neurology. 54:2000;564-574.
2. Attal N., Guirimand F., Brasseur L., Gaudé V., Chauvin M., Bouhassira D. Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology. 58:2002;554-563.
3. Attal N., Rouaud J., Brasseur L., Chauvin M., Bouhassira D. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology. 62:2004;218.
4. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain. 16:(Suppl):2000;S12-S20.
5. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 92:2001;147-157.
6. Boureau F., Doubrere J.F., Luu M. Study of verbal description in neuropathic pain. Pain. 42:1990;145-152.
7. Cleeland C.S., Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 23:1994;129-138.
8. Eide P.K., Jorum E., Stubhaug A., Bremmes J., Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 58:1994;347-354.
9. Eide P.K., Stubhaug A., Oye I., Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 61:1995;221-228.
10. Fruhstorfer H., Lindblom U., Schmidt W.C. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry. 39:1976;1071-1075.
11. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 48:1997;332-338.
12. Galer B.S., Jensen M.P., Ma T., Davies P.S., Rowbotham M.C. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 18:2002;297-301.
13. Hansson P. Difficulties in stratifying neuropathic pain by mechanisms. Eur J Pain. 7:2003;353-357.
14. Hansson P., Lindblom U. Hyperalgesia assessed with quantitative sensory testing in patients with neurogenic pain. Willis W.D. Hyperalgesia and allodynia. 1992;335-343 Raven, New York.
15. Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 102:2003;1-8.
16. Krause S.J., Backonja M. Development of a neuropathic pain questionnaire. Clin J Pain. 19:2003;306-314.
17. Leung A., Wallace M.S., Ridgeway B., Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 91:2001;177-187.
18. Masson E.A., Hunt L., Gem J.M., Boulton J.M. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain. 38:1989;25-28.
19. Max M.B. Is mechanism-based pain treatment attainable? Clinical trials issues. J Pain. 1:(Suppl 1):2000;2-9.
20. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1:1975;275-299.
21. Otto M., Bak S., Bach F.W., Jensen T.S., Sindrup S.H. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain. 101:2003;187-192.
22. Shrout D.E., Fleiss J.L. Intra-class correlation: uses in assessing rater reliability. Psychol Bull. 86:1979;420-428.
23. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
24. Vestergaard K., Andersen G., Gottrup H., Kristensen B.T., Jensen T.S. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 56:2001;184-190.
25. Wallace M.S., Magnuson S., Ridgeway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double blind placebo controlled crossover study. Reg Anesth Pain Med. 25:2000;459-467.
26. Wallace M.S., Ridgeway B.M., Leung A.Y., Gerayli A., Yaksh T.L. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology. 92:2000;75-83.
27. Woolf C.J., Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain. Suppl 6:1999;141-147.
28. Woolf C.J., Mannion R.J. Neuropathic pain aetiology, symptoms, mechanisms and management. Lancet. 353:1999;1959-1964.
29. Woolf C.J., Max M.B. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology. 95:2001;241-249.
30. Woolf C.J., Bennett G.J., Doherty M., Dubner R., Kidd B., Koltzenburg M., Lipton R., Loeser J.D., Payne R., Torebjork E. Towards a mechanism-based classification of pain? Pain. 77:1998;227-229.
31. Yarnitsky D. Quantitative sensory testing. Muscle Nerve. 20:1997;198-204.
32. Zaslansky R., Yarnitsky D. Clinical applications of quantitative sensory testing (QST). J Neurol Sci. 153:1998;215-238.